Frank R. Burns

Frank R. Burns

Auto-generated profile, based on publicly available information

Frank R. Burns

DuPont Stine-Haskell, Newark, DE, USA

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1989 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
FBF R Burns
F R Burns
XLX B Li
X B Li
NSN Shen
N Shen
HOH Offner
H Offner
YCY K Chou
Y K Chou
EHE Heber-Katz
E Heber-Katz
Prospects for specific immune intervention in T cell-mediated autoimmune disease via anti-idiotypic regulation depend on the degree of diversity of the responder cell antigen receptor repertoire. A highly heterogenous response against self epitopes offers little chance for such regulation. We report here that the Lewis rat autoimmune disease experimental allergic encephalomyelitis, generally considered to be a model of human multiple sclerosis, is caused by T cells that use a limited set of TCR V genes. We have cloned the rat TCR alpha and beta chain cDNAs from the Lewis rat x mouse T cell hybridoma 510, which retains the rat specificity for the encephalitogenic determinant of myelin basic protein (MBP). Using Northern blot analysis of T cell RNA with the cloned V region probes, we have found a specific, and near perfect, correlation between expression of TCR message hybridizing to the V alpha 510 and VB510 probes and specificity for the encephalitogenic determinant of MBP in both T cell hybridomas and encephalitogenic T cell clones. This restricted V gene usage provides a basis for observed idiotypic regulation of auto-reactive T cells, and possible therapy for autoimmune disease. A curious and unexplained observation is that the Lewis rat V alpha/V beta combination that dominates the encephalitogenic response to the 68-88 peptide of MBP is precisely the same V alpha/V beta combination used by the B10.PL mouse response to the encephalitogenic response to the 1-9 peptide of MBP.

1 August 1991 in Neuron
Verified
Journal Article
Closed access
FBFrank R. Burns
Frank R. Burns
SKStephanie von Kannen
Stephanie von Kannen
LGLeslie Guy
Leslie Guy
JRJonathan A. Raper
Jonathan A. Raper
JKJohn Kamholz
John Kamholz
SCSusannah Chang
Susannah Chang

1 May 2001 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
CMCynthia M. Magro
Cynthia M. Magro
ACA. Neil Crowson
A. Neil Crowson
AKAl J. Kovatich
Al J. Kovatich
FBFrank Burns
Frank Burns

1 August 2002 in Human Pathology
Verified
Journal Article
Closed access
CMCynthia Magro
Cynthia Magro
ACA.Neil Crowson
A.Neil Crowson
AKAl Kovatich
Al Kovatich
FBFrank Burns
Frank Burns

1 February 2003 in Human Pathology
Verified
Journal Article
Closed access
CMCynthia M. Magro
Cynthia M. Magro
ACA.Neil Crowson
A.Neil Crowson
AKAl J. Kovatich
Al J. Kovatich
FBFrank Burns
Frank Burns

17 February 1995 in Science
Verified
Journal Article
Closed access
PDF file
JDJames G. Davis
James G. Davis
JOJ. Carl Oberholtzer
J. Carl Oberholtzer
FBFrank R. Burns
Frank R. Burns
MGMark I. Greene
Mark I. Greene
Molecular biological studies of the mammalian inner ear have been limited by the relatively small size of the sensory endorgans contained within. The saccular otolithic organ in teleostian fish is structurally similar to its mammalian counterpart but can contain an order of magnitude more sensory cells. The prospect of the evolutionary conservation of proteins utilized in the vertebrate inner ear and the relative abundance of teleostian saccular sensory tissue made this an attractive system for molecular biological studies. A complementary DNA obtained by differential screening of a saccular complementary DNA library was identified that encodes an inner ear-specific collagen molecule.